Cryptogenic Multifocal Ulcerous Stenosing Enteritis C4302263
A rare bowel disorder causing multiple ulcers and narrowing of the intestines. Primarily affects adults and can be challenging to treat.
Key facts at a glance
- ICD-10
- K76.9
- ICD-11
- DA00.0
- Body system
- gastrointestinal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
GI bleeding
Abdominal pain
(gastrointestinal)Abdominal pain or nausea
(gastrointestinal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Intestinal obstruction
(gastrointestinal)Weight loss
(gastrointestinal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Anti-inflammatory and immunomodulatory therapy
Corticosteroids and other anti-inflammatory agents to reduce intestinal inflammation and promote healing of ulcerative lesions. Response varies among patients.
GI disease management
Active treatment with regular monitoring by a healthcare provider is recommended.
Exclusive or supplemental enteral nutrition
Liquid formula-based nutrition to provide bowel rest while maintaining nutritional status during active disease flares. May be used as primary therapy or adjunct to medications.
Additional treatment options
Strictureplasty or bowel resection
Surgical intervention to relieve symptomatic intestinal obstruction caused by strictures. May involve strictureplasty to widen narrowed segments or resection of severely affected bowel.
surgicalRegular endoscopic and imaging surveillance
Periodic endoscopy and imaging studies to assess disease activity, monitor for stricture development, and evaluate treatment response. Guides ongoing management decisions.
monitoringBiologic therapy
Targeted biologic agents may be considered for patients not responding to conventional therapy. These medications modify specific inflammatory pathways involved in disease pathogenesis.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Cryptogenic Multifocal Ulcerous Stenosing Enteritis C4302263?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Cryptogenic Multifocal Ulcerous Stenosing Enteritis C4302263. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy